Healthcare Delivery Life Sciences

Genetic profiling tests may hold the key for beating Cancer

It is vital for oncologists to get clinically actionable and timely results to decide on treatment options for patients. Keeping this in mind, StrandAdvantage, a tumor genomic profiling test by Strand Life Sciences, was launched in India about a year ago.

Strand Life Sciences is a global genomic profiling & bioinformatics company focusing on the use of precision medicine diagnostics aimed at cancer care and inherited diseases.In 2016, Strand made its new 152-gene test available to physicians across India for expanded tumor profiling, compared to the existing Tissue-Specific Tests for colon, lung, and breast cancers, and the 48-gene test for rare and aggressive cancers.

Healthcare Delivery

HER2 Breast Cancer and how to handle the diagnosis and treatment

Breast cancer is one of the most common cancers affecting women, but did you know that there are various types of breast cancers. One such type is HER2-positive breast cancer, in which the breast cancer cells have more HER2 receptors (a particular protein found on the surface of cells) than normal breast cells.

About 1 of every 5 breast cancers is detected to be HER2-positive breast cancer. HER2-positive breast cancer is considered aggressive because it grows and spreads quickly.


Knowing as much as you can about your breast cancer type helps you best work with your doctor/physician/oncologist to optimize treatment. HER2 status testing is done on a biopsy sample taken from the tumour. There are two ways to test HER2 status: Immunohistochemistry (IHC) that measures the amount of HER2 protein in the cancer cells and Fluorescence in situ hybridization (FISH) that looks at the number of copies of the HER2 gene in the cancer cells. The FISH test helps confirm the diagnosis and guide treatment.


The type of breast cancer is important to guide your doctor to plan appropriate cancer treatment. Treatment for HER2-positive cancer tends to be less responsive to hormonal treatment. This could be because HER2-positive breast cancer tends to be more aggressive than other types of breast cancer. However, treatments that specifically target HER2 are effective. Drugs that specifically block HER2 to stop the growth of cancer cells are called HER2-targeted therapies. Examples of these drugs include trastuzumab, lapatinib, pertuzumab, and ado-trastuzumab emtansine.



When educating yourself about HER2-positive breast cancer, explore online resources and patient related information. Experienced survivors can provide both information and support. Be sure your oncologist is also knowledgeable and up-to date on research developments, and don’t be afraid to seek a second opinion.
 is a one-of-a-kind initiative from Sorento Healthcare Communications Pvt Ltd, to provide support to HER2 positive breast cancer patients. The initiative is a completely unbiased support service which will help HER2 positive breast cancer patients and their caregivers to get encouraged in opting for the right treatment for their condition. IamHER2 helps patients with an ecosystem of resources to facilitate expert opinion, affordable testing, counselling, chat with other survivors, and treatment along with all the other ancillary services required like counselling, nutrition, psychological support etc.

About the author


Dr Rasika Bhat

Dr Bhat is Senior Manager – Medical communication solutions heads a team of medical content writers and editors and responsible for developing medical communication strategy and knowledge initiatives for continuous medical education. She has about 10 years of experience in clinical practice and medical communications. She has been associated with social initiatives namely iamHER2 (for HER2 positive patients) and pollution smokers (air pollution and lung cancer)

Healthcare Technology

Cognitive Computing: Cancer Cure for India?

A utopia, in which all the published data (new and existing) related to medical field is assimilated, understood and provides insights, could be a reality very soon. Cognitive computing technology could be the next transformative force propelling the healthcare industry towards the next era.  In 2015, near 44, 000 oncology research papers were published globally which mounts down to almost 122 new papers per day. Not even the best of human mind can tackle this tsunami of data let alone utilization of this for providing more efficient treatment to the patients. A technology which can help the doctors to utilize this vast amount of data for the benefit of the patients could be a game changer.

Healthcare Delivery Public Health

5 tips to manage constipation due to breast cancer chemotherapy

Chemotherapy is one of the treatment options that offer hope to many women with breast cancer. But it can also cause some unwanted side effects ranging from hair loss and constipation, to more serious complications. Accepting a diagnosis of breast cancer is difficult enough, and to add to that, the side effects related to its treatment can sometimes further demotivate patients.